GRUSKIN DANIEL (Chief Medical Officer) sold 30.6% of their position (1.47K shares) of LOGICBIO THERAPEUTICS, INC. on the open market
Open‑market sale worth $6.4K — a major position exit. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 8/10/2021ACC: 0001209191-21-050681
Officer· Chief Medical Officer
Since May 2021
-1.47K
Net shares
Net seller
$6.4K
Total sold
1
Open market trades
0B · 1S
3
Total transactions
4.80K acquired · 6.26K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+4.80K
Price / share
—
Trade value
—
% of position
New position
8/6/2021
0.00→4.80K
Common Stock
Direct
Shares
−1.47K
Price / share
$4.35
Trade value
$6.38K
% of position
30.6%
8/9/2021
4.80K→3.33K
Total
Net shares
+3.33K
Net value
-$6.38K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 8/6/2021 | M · Option Exercise | +4.80K | — | — | New position | 0.00 | 4.80K |
| Common Stock Direct | 8/9/2021 | S · Sale | −1.47K | $4.35 | $6.38K | 30.6% | 4.80K | 3.33K |
| Total | +3.33K | -$6.38K | ||||||
Derivative Transactions1
Restricted Stock Units
Direct
Converts to
Common Stock
4.80K shares
Shares
−4.80K
Strike price
Held after
0.00
Exercisable
—
8/6/2021
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Restricted Stock Units Direct | Common Stock4.80K shares | 8/6/2021 | M · Option Exercise | −4.80K | — | 0.00 |